ENTA

Enanta Pharmaceuticals Inc

13.76

+0.31+2.30%

After Hours: 13.76 0.00 0.00%16:10 05/19 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE13.47/13.45

TODAY RANGE13.35-13.91

VOL203.87K

MARKET CAP400.12M

52 WEEK RANGE5.55-17.15

AVG VOL (3M)170.75K

% TURNOVER0.70%

TURNOVER--

P/E (TTM)-5.3029

% RANGE3.94%

EPS(TTM)-2.5948

P/E(FORWARD)-6.3119

P/B3.430

BVPS4.012

DIVIDEND--

P/S4.505

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP380.67M

SHARES OUTSTANDING29.08M

NEXT EARNINGS08/06-08/08

FREE FLOAT27.66M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·05/12 15:10
Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Orchestra BioMed Holdings (OBIO)
TipRanks·05/11 21:39
Enanta reports Q2 EPS (45), consensus (49c)
Reuters·05/11 20:11
Enanta Pharma Q2 loss narrows on higher AbbVie royalties, lower costs
Seeking Alpha·05/11 20:05
Enanta Pharma GAAP EPS of -$0.45 beats by $0.04, revenue of $17.16M beats by $0.07M
PUBT·05/11 20:01
Enanta FY26 Q2 net loss narrows to $13.1 million; revenue rises to $17.2 million
Reuters·05/11 20:01
BRIEF-Enanta Pharmaceuticals Q2 Revenue USD 17.159 Million Vs. IBES Estimate USD 17.1 Million
Dow Jones·05/11 20:01
Press Release: Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026
Dow Jones·05/11 20:01
*Enanta Pharmaceuticals 2Q Rev $17.2M >ENTA
Dow Jones·05/11 20:01
Press Release: Enanta Pharmaceuticals Reports -3-
Dow Jones·05/11 20:01
Press Release: Enanta Pharmaceuticals Reports -2-
Dow Jones·05/11 20:01
*Enanta Pharmaceuticals 2Q Loss $13.1M >ENTA
Dow Jones·05/11 20:01
*Enanta Pharmaceuticals 2Q Loss/Shr 45c >ENTA
PUBT·05/04 11:00
Enanta says Phase 2 trial shows zelicapavir reduces RSV symptom duration, hospitalization
TipRanks·04/21 10:20
Analysts’ Top Healthcare Picks: Q32 Bio (QTTB), UnitedHealth (UNH)
TipRanks·04/13 11:12
Enanta announces first participant dosed in Phase 1 trial of EDP-978

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

+1.79%

760.57

BIIB

Amgen Inc

AMGN

-0.59%

324.39

SHPG

CELG-RT

LLY

Celgene

CELG

0.00%

108.24

TXMD

JNJ

ABBV

ZTS

Gilead Sciences Inc

GILD

-1.88%

129.58

Novo-Nordisk A/S

NVO

-2.31%

44.74

Bristol-Myers Squibb Co

BMY

+0.96%

57.86

ALXN

PFE

SNY

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-1.13%

148.08

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.